|
![]() |
|||
|
||||
OverviewFull Product DetailsAuthor: Alan H. B. Wu , Kiang-Teck J. YeoPublisher: Humana Press Inc. Imprint: Humana Press Inc. Edition: 2011 ed. Dimensions: Width: 15.50cm , Height: 2.30cm , Length: 23.50cm Weight: 0.444kg ISBN: 9781617797262ISBN 10: 161779726 Pages: 272 Publication Date: 19 April 2013 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: Manufactured on demand ![]() We will order this item for you from a manufactured on demand supplier. Table of ContentsPart 1. Basic concepts Chapter 1. Issues in Translation of Pharmacogenomics into Clinical Practice. Kiang-Teck J. Yeo, Nikolina Babic, Alan H.B. Wu Chapter 2. Molecular Diagnostic Methods in Pharmacogenomics Nikolina Babic*, Loren J. Joseph, Kiang-Teck J. Yeo Chapter 3. Economics of pharmacogenomic testing in clinical practice Alan H.B. Wu Chapter 4. From Personalized Medicine to Personalized Justice: The Promises of Translational Pharmacogenomics in the Justice System Steven H.Y. Wong, Christopher Happy, Daniel Blinka, Susan Goch, Jeffrey M. Jensen, Joseph M. Donald, Howard Coleman, Saeed A. Jortani, Yolanda Lurie, Cynthia L. Morris-Kukoski, Manuela G. Newman, Paul J. Orsulak, Tara Sander, Michael A. Wagner, Jennifer R. Wynn, Alan H.B. Wu, Kiang-Teck J. Yeo. Part 2. Specific pharmacogenomic targets: Chemotherapeutics Chapter 5. Irinotecan R. Stephanie Huang, Federico Innocenti and Mark J. Ratain Chapter 6. Pharmacogenomics of tamoxifen Christine LH Snozek, Alicia Algeciras-Schimnich, Matthew P Goetz, Loralie J Langman Chapter 7. Thiopurines Terreia S. Jones, Mary V. Relling Part 3. Specific pharmacogenomic targets: Cardiovascular drugs Chapter 8. The Pharmacogenetics of Vitamin K Antagonist Anticoagulation Drugs Charles Eby Chapter 9. Clopidogrel and Salicylates Janice Y Chyou, Marc S Sabatine Chapter 10. DNA-Guided Statin Therapy Gualberto Ruaño, Richard L. Seip, Jorge Duconge Chapter 11. The statin response gene: Kif6 ....................... H. Robert Superko, Tom White, James Forrester, Spencer King III. Part 4. Drugs that cause delayed hypersensitivity Chapter 12. Abacavir Elizabeth J. Phillips, Simon A. Mallal Chapter 13. Allopurinol Pei Chen, Shuen-Iu Hung, Shih-Yang Chen, Yuan-Tsong Chen Chapter 14. Carbamazepine and its structurally-related antiepiletics Shuen-Iu Hung, Wen-Hung Chung, Jing-Jane Tsai, Yuan-Tsong Chen Part 5........ Miscellaneous drugs Chapter 15. Pharmacogenetics of Flucloxacillin and Amoxicillin-Clavulanate Associated Hepatic Dysfunction/Injury Hong-Kee Lee, Lionel D. Lewis Chapter 16. Immunosuppressants Pharmacogenomics Ping Wang Steven H.Y. Wong, Christopher Happy, Daniel Blinka, Susan Goch, Jeffrey M. Jensen, Joseph M. Donald, Howard Coleman, Saeed A. Jortani, Yolanda Lurie, Cynthia L. Morris-Kukoski, Manuela G. Newman, Paul J. Orsulak, Tara Sander, Michael A. Wagner, Jennifer R. Wynn, Alan H.B. Wu, Kiang-Teck J. Yeo. Part 2. Specific pharmacogenomic targets: Chemotherapeutics Chapter 5. Irinotecan R. Stephanie Huang, Federico Innocenti and Mark J. Ratain Chapter 6. Pharmacogenomics of tamoxifen Christine LH Snozek, Alicia Algeciras-Schimnich, Matthew P Goetz, Loralie J Langman Chapter 7. Thiopurines Terreia S. Jones, Mary V. Relling Part 3. Specific pharmacogenomic targets: Cardiovascular drugs Chapter 8. The Pharmacogenetics of Vitamin K Antagonist Anticoagulation Drugs Charles Eby Chapter 9. Clopidogrel and Salicylates Janice Y Chyou, Marc S Sabatine Chapter 10. DNA-Guided Statin Therapy Gualberto Ruaño, Richard L. Seip, Jorge Duconge Chapter 11. The statin response gene: Kif6 ....................... H. Robert Superko, Tom White, James Forrester, Spencer King III. Part 4. Drugs that cause delayed hypersensitivity Chapter12. Abacavir Elizabeth J. Phillips, Simon A. Mallal Chapter 13. Allopurinol Pei Chen, Shuen-Iu Hung, Shih-Yang Chen, Yuan-Tsong Chen Chapter 14. Carbamazepine and its structurally-related antiepiletics Shuen-Iu Hung, Wen-Hung Chung, Jing-Jane Tsai, Yuan-Tsong Chen Part 5........ Miscellaneous drugs Chapter 15. Pharmacogenetics of Flucloxacillin and Amoxicillin-Clavulanate Associated Hepatic Dysfunction/Injury Hong-Kee Lee, Lionel D. Lewis Chapter 16. Immunosuppressants Pharmacogenomics Ping Wang Chapter 14. Carbamazepine and its structurally-related antiepiletics Shuen-Iu Hung, Wen-Hung Chung, Jing-Jane Tsai, Yuan-Tsong Chen Part 5........ Miscellaneous drugs Chapter 15. Pharmacogenetics of Flucloxacillin and Amoxicillin-Clavulanate Associated Hepatic Dysfunction/Injury Hong-Kee Lee, Lionel D. Lewis Chapter 16. Immunosuppressants Pharmacogenomics Ping WangReviewsFrom the reviews: The book is written for clinical laboratory directors 'contemplating or assigned the task of establishing a pharmacogenomics laboratory,' pharmacologists, and interested clinicians who may have to interpret results. This book also would be of interest to ... allied health practitioners, regulators, reimbursers, and test device manufacturers. ... The writing is concise, clear, and accessible for what might be considered a complex topic. ... Get this book if you want a quick, concise, and fascinating read about the current world and use of pharmacogenomic testing. (Valerie L. Ng, Doody's Review Service, May, 2011) From the reviews: The book is written for clinical laboratory directors `contemplating or assigned the task of establishing a pharmacogenomics laboratory,' pharmacologists, and interested clinicians who may have to interpret results. This book also would be of interest to ... allied health practitioners, regulators, reimbursers, and test device manufacturers. ... The writing is concise, clear, and accessible for what might be considered a complex topic. ... Get this book if you want a quick, concise, and fascinating read about the current world and use of pharmacogenomic testing. (Valerie L. Ng, Doody's Review Service, May, 2011) Author InformationTab Content 6Author Website:Countries AvailableAll regions |